Fiducial markers coupled with 3D PET/CT offer more accurate radiation treatment delivery for locally advanced esophageal cancer

Abstract

Background and aims The role of three-dimensional positron emission tomography/computed tomography (3 D PET/CT) in esophageal tumors that move with respiration and have potential for significant mucosal inflammation is unclear. The aim of this study was to determine the correlation between gross tumor volumes derived from 3 D PET/CT and endoscopically placed fiducial markers.

Methods This was a retrospective, IRB approved analysis of 40 patients with esophageal cancer with fiducials implanted and PET/CT. The centroid of each fiducial was identified on PET/CT images. Distance between tumor volume and fiducials was measured using axial slices. Image features were extracted and tested for pathologic response predictability.

Results The median adaptively calculated threshold value of the standardized uptake value (SUV) to define the metabolic tumor volume (MTV) border was 2.50, which corresponded to a median 23 % of the maximum SUV. The median distance between the inferior fiducial centroid and MTV was – 0.60 cm (– 3.9 to 2.7 cm). The median distance between the superior fiducial centroid and MTV was 1.25 cm (– 4.2 to 6.9 cm). There was no correlation between MTV-to-fiducial distances greater than 2 cm and the gastroenterologist who performed the fiducial implantation. Eccentricity demonstrated statistically significant correlations with pathologic response.

Conclusions There was a stronger correlation between inferior fiducial location and MTV border compared to the superior extent. The etiology of the discordance superiorly is unclear, potentially representing benign secondary esophagitis, presence of malignant nodes, inflammation caused by technical aspects of the fiducial placement itself, or potential submucosal disease. Given the concordance inferiorly and the ability to more precisely set up the patient with daily image guidance matching to fiducials, it may be possible to minimize the planning tumor volume (PTV) margin in select patients, thereby, limiting dose to normal structures.

• References

• 1 American Cancer Society. Cancer facts & figures 2015. Atlanta: 2015
• 2 Tixier F, Le Rest CC, Hatt M. et al. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 2011; 52: 369-378
• 3 Shridhar R, Almhanna K, Meredith KL. et al. Radiation therapy and esophageal cancer. Cancer Control 2013; 20: 97-110
• 4 Dittrick GW, Weber JM, Shridhar R. et al. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy. Ann Surg Oncol 2012; 19: 1678-1684
• 5 Spratt DE, Diaz R, McElmurray J. et al. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer. Clin Nucl Med 2010; 35: 237-243
• 6 Zheng Y, Sun X, Wang J. et al. FDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer. Oncol Lett 2014; 7: 1015-1020
• 7 Gregoire V, Haustermans K, Geets X. et al. PET-based treatment planning in radiotherapy: a new standard?. J Nucl Med 2007; 48 (Suppl. 01) 68S-77S
• 8 Grégoire V, Haustermans K, Lee J. Chapter 20. Molecular image-guided radiotherapy with positron emission tomography; 20.3 PET image segmentation. In: Joiner MC, van der Kogel A. , eds. Basic Clinical Radiobiology. 4th edn. CRC Press; 2009: 271-286
• 9 Wang YC, Hsieh TC, Yu CY. et al. The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer. J Radiat Res 2012; 53: 594-600
• 10 Westerterp M, Westreenen HLv, Reitsma JB. et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy – systematic review. Radiology 2005; 236: 841-851
• 11 Wieder HA, Ott K, Lordick F. et al. Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction. Eur J Nucl Med Mol Imaging 2007; 34: 1925-1932
• 12 Lordick F, Ott K, Krause BJ. et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 2007; 8: 797-805
• 13 Muijs CT, Beukema JC, Pruim J. et al. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol 2010; 97: 165-171
• 14 Fernandez DC, Hoffe SE, Barthel JS. et al. Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy. Pract Radiat Oncol 2013; 3: 32-39
• 15 Fukada J, Hanada T, Kawaguchi O. et al. Detection of esophageal fiducial marker displacement during radiation therapy with a 2-dimensional on-board imager: analysis of internal margin for esophageal cancer. Int J Radiat Oncol Biol Phys 2013; 85: 991-998
• 16 McBride GB. Equivalence measures for comparing the performance of alternative methods for the analysis of water quality variables. Auckland, New Zealand: National Institute of Water & Atmospheric Research Ltd; 2007
• 17 Oliver JA, Budzevich M, Zhang GG. et al. Variability of image features computed from conventional and respiratory-gated PET/CT images of lung cancer. Transl Oncol 2015; 8: 524-534
• 18 Haralick RM, Shanmugam K, Dinstein IH. Textural features for image classification. IEEE Trans Systems Man Cybernet 1973; SMC-3 610-621
• 19 Galloway MM. Texture analysis using gray level run lengths. Comput Graph Image Process 1975; 4: 172-179
• 20 Tustison NJ, Gee JC. Run length matrices for texture analysis. Insight J; 2008. http://hdl.handle.net/1926/1374
• 21 Thibault G, Fertil B, Navarro C. et al. Texture indexes and gray level size zone matrix. Application to cell nuclei classification. Pattern Recognit Inf Process 2009; 140-145
• 22 Xu D-H, Kurani AS, Furst JD, Raicu DS. Run-length encoding for volumetric texture. The 4th IASTED International Conference on Visualization, Imaging and Image Processing; VIIP. Marbella, Spain: 2004
• 23 Kurani AS, Xu D-H, Furst JD, Raicu DS. Co-occurrence matrices for volumetric data. Paper presented at: The 7th IASTED International Conference on Computer Graphics and Imaging; CGIM. August 17–19, Kauai, Hawaii, United States: 2004
• 24 El Naqa I, Grigsby P, Apte A. et al. Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 2009; 42: 1162-1171
• 25 Murphy KR, Myors B. Statistical power analysis: A simple and general model for traditional and modern hypothesis tests. 2nd edn. Mahwah, NJ: Lawrence Erlbaum Associates; 2004
• 26 Jin P, Hulshof MC, de Jong R. et al. Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography. Radiother Oncol 2016; 118: 492-497
• 27 Yamashita H, Kida S, Sakumi A. et al. Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer. Int J Radiat Oncol Biol Phys 2011; 79: 588-595
• 28 Machiels M, Van Hooft J, Jin P. et al. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers. Gastrointest Endosc 2015; 82: 641-649
• 29 Freilich J, Hoffe SE, Almhanna K. et al. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer. Dis Esophagus 2015; 28: 352-357
• 30 American Cancer Society. Cancer facts & figures 2010. Atlanta: 2010
• 31 American Cancer Society. Cancer facts & figures 2011. Atlanta: 2011
• 32 American Cancer Society. Cancer facts & figures 2012. Atlanta: 2012
• 33 Venkat P, Oliver JA, Jin W. et al. Prognostic value of ¹⁸F-FDG PET/CT metabolic tumor volume for complete pathologic response and clinical outcomes after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. J Nucl Med Radiat Ther 2016; 7: 1-8
• 34 Venkat P, Shridhar R, Naghavi AO. et al. Pathologic complete response and dose-escalation with preoperative dose painting IMRT chemoradiation in esophageal cancer. Int J Radiat Oncol Biol Phys 2015; 93: S219-S220
• 35 Shapiro J, van Lanschot JJ, Hulshof MC. et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 2015; 16: 1090-1098
• 36 Bouchard M, McAleer MF, Starkschall G. Impact of gastric filling on radiation dose delivered to gastroesophageal junction tumors. Int J Radiat Oncol Biol Phys 2010; 77: 292-300
• 37 Zhong X, Yu J, Zhang B. et al. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009; 73: 136-141
• 38 Latifi K, Zhang G, Stawicki M. et al. Validation of three deformable image registration algorithms for the thorax. J Appl Clin Med Phys 2013; 14: 3834
• 39 O’Sullivan F, Roy S, O’Sullivan J. et al. Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET. Biostatistics 2005; 6: 293-301